Evgen Pharma's total assets for Q2 2025 were £6.62M, a decrease of -13.26% from the previous quarter. GB:TCF total liabilities were £1.82M for the fiscal quarter, a 9.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.